German English

Bogen 2 Verlaufsbogen Seite 1 von 2

1 forms  
  1. StudyEvent: Bogen 2 Verlaufsbogen Seite 1 von 2
    1. Bogen 2 Verlaufsbogen Seite 1 von 2
Adiminstrative Daten I
Description

Adiminstrative Daten I

Klinik-Nr.
Description

Klinik-Nr.

Data type

integer

Alias
Code-1
Identifier
UMLS CUI 2011AB
C0600091
SNOMEDCT_2012_01_31
118522005
Code-2
Hospitals
UMLS CUI 2011AB
C0019994
LOINC Version 232
MTHU002722
Patienten-Nr.
Description

Patienten-Nr.

Data type

integer

Alias
Code-1
Identifier
UMLS CUI 2011AB
C0600091
SNOMEDCT_2012_01_31
118522005
Code-2
Patients
UMLS CUI 2011AB
C0030705
SNOMEDCT_2012_01_31
116154003
Geburtsdatum
Description

Geburtsdatum

Geburtsmonat
Description

Geburtsmonat

Data type

integer

Alias
Code-1
month
UMLS CUI 2011AB
C0439231
SNOMEDCT_2012_01_31
258706009
HL7 V3 2006_05
MO
Geburtstag
Description

Geburtstag

Data type

integer

Alias
Code-1
day
UMLS CUI 2011AB
C0439228
SNOMEDCT_2012_01_31
258703001
LOINC Version 232
MTHU039849
HL7 V3 2006_05
D
Adiminstrative Daten II
Description

Adiminstrative Daten II

Beurteilungsdatum
Description

Beurteilungsdatum

Data type

date

Alias
Code-1
Evaluation
UMLS CUI 2011AB
C0220825
Code-2
Date in time
UMLS CUI 2011AB
C0011008
SNOMEDCT_2012_01_31
410671006
LOINC Version 232
MTHU021546
Nummer des Verlaufsbogen
Description

Nummer des Verlaufsbogen

Data type

integer

Alias
Code-1
Follow-Up Report
UMLS CUI 2011AB
C1704685
Code-2
Numbers
UMLS CUI 2011AB
C0237753
SNOMEDCT_2012_01_31
410680006
LOINC Version 232
MTHU024869
Geschlecht
Description

Geschlecht

Data type

integer

Alias
Code-1
Patient sex
UMLS CUI 2011AB
C0150831
SNOMEDCT_2012_01_31
184100006
Therapiephase
Description

Therapiephase

Erreichen des Therapiezieles der Induktionsphase (nach mindestens 24 Monaten Behandlung) am:
Description

Erreichen des Therapiezieles der Induktionsphase (nach mindestens 24 Monaten Behandlung und 2-facher MMR) am:

Data type

date

Alias
Code-1
Achievement
UMLS CUI 2011AB
C0001072
Code-2
treatment goals
UMLS CUI 2011AB
C0679840
Code-3
Induction
UMLS CUI 2011AB
C0857127
MedDRA 14.1
10021721
Code-4
Phase
UMLS CUI 2011AB
C0205390
SNOMEDCT_2012_01_31
21191007
Code-5
Post
UMLS CUI 2011AB
C0231290
SNOMEDCT_2012_01_31
255234002
Code-6
Minimum
UMLS CUI 2011AB
C1524031
Absetzdatum von Nilotinib im Kombinationsarm am:
Description

Absetzdatum von Nilotinib im Kombinationsarm am:

Data type

date

Alias
Code-1
Date treatment stopped (observable entity)
UMLS CUI 2011AB
C1531784
SNOMEDCT_2012_01_31
413947000
Code-2
Nilotinib
UMLS CUI 2011AB
C1721377
SNOMEDCT_2012_01_31
428468009
Code-3
Combination
UMLS CUI 2011AB
C1947911
Code-4
Protocol Treatment Arm
UMLS CUI 2011AB
C1522541
Erreichen der Hauptphase (nach mindestens 12 Monaten Behandlung) am:
Description

Erreichen der Hauptphase (nach mindestens 12 Monaten Behandlung und mindestens 12 Monaten kontinuierlicher MR4) am:

Data type

date

Alias
Code-1
Achievement
UMLS CUI 2011AB
C0001072
Code-2
Main
UMLS CUI 2011AB
C1542147
Code-3
Phase
UMLS CUI 2011AB
C0205390
SNOMEDCT_2012_01_31
21191007
Code-4
Post
UMLS CUI 2011AB
C0231290
SNOMEDCT_2012_01_31
255234002
Code-5
Minimum
UMLS CUI 2011AB
C1524031
Code-6
One
UMLS CUI 2011AB
C0205447
SNOMEDCT_2012_01_31
421379005
Absetzdatum der Hauptphasentherapie am:
Description

Absetzdatum der Hauptphasentherapie am:

Data type

date

Alias
Code-1
Date treatment stopped (observable entity)
UMLS CUI 2011AB
C1531784
SNOMEDCT_2012_01_31
413947000
Code-2
Main
UMLS CUI 2011AB
C1542147
Code-3
Phase
UMLS CUI 2011AB
C0205390
SNOMEDCT_2012_01_31
21191007
Code-4
Therapeutic procedure
UMLS CUI 2011AB
C0087111
SNOMEDCT_2012_01_31
277132007
MedDRA 14.1
10053757
LOINC Version 232
MTHU021209
Bisherige Therapie im Intervall
Description

Bisherige Therapie im Intervall

Nilotinib 2*300mg
Description

Nilotinib 2*300mg

andere Dosis (mg)
Description

andere Dosis (mg)

Data type

integer

Alias
Code-1
Other
UMLS CUI 2011AB
C0205394
SNOMEDCT_2012_01_31
74964007
Code-2
Dosage
UMLS CUI 2011AB
C0178602
SNOMEDCT_2012_01_31
260911001
Code-3
Milligram
UMLS CUI 2011AB
C0439210
SNOMEDCT_2012_01_31
258684004
Beginn
Description

Beginn

Data type

date

Alias
Code-1
Date treatment started (observable entity)
UMLS CUI 2011AB
C3173309
SNOMEDCT_2012_01_31
413946009
Code-2
Nilotinib
UMLS CUI 2011AB
C1721377
SNOMEDCT_2012_01_31
427941004
Code-3
Twice
UMLS CUI 2011AB
C1948050
Code-4
Three
UMLS CUI 2011AB
C0205449
SNOMEDCT_2012_01_31
421291004
Code-5
One Hundred
UMLS CUI 2011AB
CL447292
Code-6
Milligram
UMLS CUI 2011AB
C0439210
SNOMEDCT_2012_01_31
258684004
Ende
Description

Ende

Data type

date

Alias
Code-1
Date treatment stopped (observable entity)
UMLS CUI 2011AB
C1531784
SNOMEDCT_2012_01_31
413947000
Code-2
Nilotinib
UMLS CUI 2011AB
C1721377
SNOMEDCT_2012_01_31
427941004
Code-3
Twice
UMLS CUI 2011AB
C1948050
Code-4
Three
UMLS CUI 2011AB
C0205449
SNOMEDCT_2012_01_31
421291004
Code-5
One Hundred
UMLS CUI 2011AB
CL447292
Code-6
Milligram
UMLS CUI 2011AB
C0439210
SNOMEDCT_2012_01_31
258684004
Therapietage
Description

Therapietage

Data type

integer

Alias
Code-1
Number
UMLS CUI 2011AB
C0449788
SNOMEDCT_2012_01_31
410681005
Code-2
Therapeutic procedure
UMLS CUI 2011AB
C0087111
SNOMEDCT_2012_01_31
277132007
MedDRA 14.1
10053757
LOINC Version 232
MTHU021209
Code-3
day
UMLS CUI 2011AB
C0439228
SNOMEDCT_2012_01_31
258703001
LOINC Version 232
MTHU039849
HL7 V3 2006_05
D
Code-4
Nilotinib
UMLS CUI 2011AB
C1721377
SNOMEDCT_2012_01_31
427941004
Code-5
Twice
UMLS CUI 2011AB
C1948050
Code-6
Three
UMLS CUI 2011AB
C0205449
SNOMEDCT_2012_01_31
421291004
Gesamtdosis (mg)
Description

Gesamtdosis (mg)

Data type

integer

Alias
Code-1
Cumulative Dose
UMLS CUI 2011AB
C2986497
Code-2
Milligram
UMLS CUI 2011AB
C0439210
SNOMEDCT_2012_01_31
258684004
Code-3
Nilotinib
UMLS CUI 2011AB
C1721377
SNOMEDCT_2012_01_31
427941004
Code-4
Twice
UMLS CUI 2011AB
C1948050
Code-5
Three
UMLS CUI 2011AB
C0205449
SNOMEDCT_2012_01_31
421291004
Code-6
One Hundred
UMLS CUI 2011AB
CL447292
Absetzen
Description

Absetzen

Data type

integer

Alias
Code-1
Stop
UMLS CUI 2011AB
C1947925
Code-2
Nilotinib
UMLS CUI 2011AB
C1721377
SNOMEDCT_2012_01_31
427941004
Code-3
Twice
UMLS CUI 2011AB
C1948050
Code-4
Three
UMLS CUI 2011AB
C0205449
SNOMEDCT_2012_01_31
421291004
Code-5
One Hundred
UMLS CUI 2011AB
CL447292
Code-6
Milligram
UMLS CUI 2011AB
C0439210
SNOMEDCT_2012_01_31
258684004
Grund für Absetzen
Description

Grund für Absetzen

Data type

integer

Alias
Code-1
Indication of (contextual qualifier)
UMLS CUI 2011AB
C0392360
SNOMEDCT_2012_01_31
410666004
LOINC Version 232
MTHU008319
Code-2
Stop
UMLS CUI 2011AB
C1947925
Code-3
Nilotinib
UMLS CUI 2011AB
C1721377
SNOMEDCT_2012_01_31
427941004
Code-4
Twice
UMLS CUI 2011AB
C1948050
Code-5
Three
UMLS CUI 2011AB
C0205449
SNOMEDCT_2012_01_31
421291004
Code-6
One Hundred
UMLS CUI 2011AB
CL447292
Grund für Absetzen
Description

Grund für Absetzen

Data type

string

Alias
Code-1
Indication of (contextual qualifier)
UMLS CUI 2011AB
C0392360
SNOMEDCT_2012_01_31
410666004
LOINC Version 232
MTHU008319
Code-2
Stop
UMLS CUI 2011AB
C1947925
Code-3
Free Text Format
UMLS CUI 2011AB
C2348713
Code-4
Nilotinib
UMLS CUI 2011AB
C1721377
SNOMEDCT_2012_01_31
427941004
Code-5
Twice
UMLS CUI 2011AB
C1948050
Code-6
Three
UMLS CUI 2011AB
C0205449
SNOMEDCT_2012_01_31
421291004
Nilotinib - Pause
Description

Nilotinib - Pause

Beginn
Description

Beginn

Data type

date

Alias
Code-1
Start Date
UMLS CUI 2011AB
C0808070
LOINC Version 232
MTHU008298
Ende
Description

Ende

Data type

date

Alias
Code-1
End Date
UMLS CUI 2011AB
C0806020
LOINC Version 232
MTHU008302
PEG-IFN
Description

PEG-IFN

Beginn
Description

Beginn

Data type

date

Alias
Code-1
Date treatment started (observable entity)
UMLS CUI 2011AB
C3173309
SNOMEDCT_2012_01_31
413946009
Code-2
Pegylated Interferon Alfa
UMLS CUI 2011AB
C0907160
Ende
Description

Ende

Data type

date

Alias
Code-1
Date treatment stopped (observable entity)
UMLS CUI 2011AB
C1531784
SNOMEDCT_2012_01_31
413947000
Code-2
Pegylated Interferon Alfa
UMLS CUI 2011AB
C0907160
Einzeldosis (μg)
Description

Einzeldosis (μg)

Data type

integer

Alias
Code-1
Single dose characteristic (observable entity)
UMLS CUI 2011AB
C1960417
SNOMEDCT_2012_01_31
426146003
Code-2
Microgram
UMLS CUI 2011AB
C0439211
SNOMEDCT_2012_01_31
258685003
Intervall (Tage)
Description

Intervall (Tage)

Data type

integer

Alias
Code-1
Interval
UMLS CUI 2011AB
C1272706
SNOMEDCT_2012_01_31
385673002
Anzahl Injektionen
Description

Anzahl Injektionen

Data type

integer

Alias
Code-1
Number
UMLS CUI 2011AB
C0449788
SNOMEDCT_2012_01_31
410681005
Code-2
Injection procedure
UMLS CUI 2011AB
C1533685
SNOMEDCT_2012_01_31
129326001
MedDRA 14.1
10052995
Absetzen
Description

Absetzen

Data type

integer

Alias
Code-1
Stop
UMLS CUI 2011AB
C1947925
Code-2
Pegylated Interferon Alfa
UMLS CUI 2011AB
C0907160
Grund für Absetzen
Description

Grund für Absetzen

Data type

integer

Alias
Code-1
Indication of (contextual qualifier)
UMLS CUI 2011AB
C0392360
SNOMEDCT_2012_01_31
410666004
LOINC Version 232
MTHU008319
Code-2
Stop
UMLS CUI 2011AB
C1947925
Code-3
Pegylated Interferon Alfa
UMLS CUI 2011AB
C0907160
Grund für Absetzen
Description

Grund für Absetzen

Data type

string

Alias
Code-1
Indication of (contextual qualifier)
UMLS CUI 2011AB
C0392360
SNOMEDCT_2012_01_31
410666004
LOINC Version 232
MTHU008319
Code-2
Stop
UMLS CUI 2011AB
C1947925
Code-3
Free Text Format
UMLS CUI 2011AB
C2348713
Code-4
Pegylated Interferon Alfa
UMLS CUI 2011AB
C0907160
PEG-IFN - Pause
Description

PEG-IFN - Pause

Beginn
Description

Beginn

Data type

date

Alias
Code-1
Start Date
UMLS CUI 2011AB
C0808070
LOINC Version 232
MTHU008298
Code-2
Pegylated Interferon Alfa
UMLS CUI 2011AB
C0907160
Code-3
Rest
UMLS CUI 2011AB
C0035253
SNOMEDCT_2012_01_31
258157001
Ende
Description

Ende

Data type

date

Alias
Code-1
End Date
UMLS CUI 2011AB
C0806020
LOINC Version 232
MTHU008302
Code-2
Pegylated Interferon Alfa
UMLS CUI 2011AB
C0907160
Code-3
Rest
UMLS CUI 2011AB
C0035253
SNOMEDCT_2012_01_31
258157001
weitere Medikation
Description

weitere Medikation

Grund
Description

Grund

Data type

string

Alias
Code-1
Indication of (contextual qualifier)
UMLS CUI 2011AB
C0392360
SNOMEDCT_2012_01_31
410666004
LOINC Version 232
MTHU008319
Code-2
Further
UMLS CUI 2011AB
C1517331
Code-3
Pharmaceutical Preparations
UMLS CUI 2011AB
C0013227
SNOMEDCT_2012_01_31
410942007
Medikament
Description

Medikament

Data type

string

Alias
Code-1
Pharmaceutical Preparations
UMLS CUI 2011AB
C0013227
SNOMEDCT_2012_01_31
410942007
Dosis
Description

Dosis

Data type

integer

Alias
Code-1
Dosage
UMLS CUI 2011AB
C0178602
SNOMEDCT_2012_01_31
277406006
Einheit
Description

Einheit

Data type

string

Alias
Code-1
Dosage Form Unit
UMLS CUI 2011AB
C2348328
Beginn
Description

Beginn

Data type

date

Alias
Code-1
Date treatment started (observable entity)
UMLS CUI 2011AB
C3173309
SNOMEDCT_2012_01_31
413946009
Code-2
Further
UMLS CUI 2011AB
C1517331
Code-3
Pharmaceutical Preparations
UMLS CUI 2011AB
C0013227
SNOMEDCT_2012_01_31
410942007
Ende
Description

Ende

Data type

date

Alias
Code-1
Date treatment stopped (observable entity)
UMLS CUI 2011AB
C1531784
SNOMEDCT_2012_01_31
413947000
Code-2
Further
UMLS CUI 2011AB
C1517331
Code-3
Pharmaceutical Preparations
UMLS CUI 2011AB
C0013227
SNOMEDCT_2012_01_31
410942007
Unterschrift
Description

Unterschrift

Kommentar
Description

Kommentar

Data type

string

Alias
Code-1
Comment
UMLS CUI 2011AB
C0947611
LOINC Version 232
MTHU013736
Klinik
Description

Klinik

Data type

string

Alias
Code-1
Hospitals
UMLS CUI 2011AB
C0019994
LOINC Version 232
MTHU002722
Datum
Description

Datum

Data type

date

Alias
Code-1
Signature date
UMLS CUI 2011AB
C0807937
LOINC Version 232
MTHU008294
Unterschrift
Description

Unterschrift

Data type

string

Alias
Code-1
Investigator Signature
UMLS CUI 2011AB
C2346576
Back to the top of the page

Similar models

Bogen 2 Verlaufsbogen Seite 1 von 2

1 forms
  1. StudyEvent: Bogen 2 Verlaufsbogen Seite 1 von 2
    1. Bogen 2 Verlaufsbogen Seite 1 von 2
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Adiminstrative Daten I
Klinik-Nr.
Item
Klinik-Nr.
integer
Identifier (Code-1)
C0600091 (UMLS CUI 2011AB)
118522005 (SNOMEDCT_2012_01_31)
Hospitals (Code-2)
C0019994 (UMLS CUI 2011AB)
MTHU002722 (LOINC Version 232)
Patienten-Nr.
Item
Patienten-Nr.
integer
Identifier (Code-1)
C0600091 (UMLS CUI 2011AB)
118522005 (SNOMEDCT_2012_01_31)
Patients (Code-2)
C0030705 (UMLS CUI 2011AB)
116154003 (SNOMEDCT_2012_01_31)
Item Group
Geburtsdatum
Geburtsmonat
Item
Geburtsmonat
integer
month (Code-1)
C0439231 (UMLS CUI 2011AB)
258706009 (SNOMEDCT_2012_01_31)
MO (HL7 V3 2006_05)
Geburtstag
Item
Geburtstag
integer
day (Code-1)
C0439228 (UMLS CUI 2011AB)
258703001 (SNOMEDCT_2012_01_31)
MTHU039849 (LOINC Version 232)
D (HL7 V3 2006_05)
Item Group
Adiminstrative Daten II
Beurteilungsdatum
Item
Beurteilungsdatum
date
Evaluation (Code-1)
C0220825 (UMLS CUI 2011AB)
Date in time (Code-2)
C0011008 (UMLS CUI 2011AB)
410671006 (SNOMEDCT_2012_01_31)
MTHU021546 (LOINC Version 232)
Nummer des Verlaufsbogen
Item
Nummer des Verlaufsbogen
integer
Follow-Up Report (Code-1)
C1704685 (UMLS CUI 2011AB)
Numbers (Code-2)
C0237753 (UMLS CUI 2011AB)
410680006 (SNOMEDCT_2012_01_31)
MTHU024869 (LOINC Version 232)
Item
Geschlecht
integer
Patient sex (Code-1)
C0150831 (UMLS CUI 2011AB)
184100006 (SNOMEDCT_2012_01_31)
Geschlecht
Code List
Geschlecht
CL Item
männlich (männlich)
Male gender (Code-1)
C0086582 (UMLS CUI 2011AB)
10052007 (SNOMEDCT_2012_01_31)
CL Item
weiblich (weiblich)
C0086287 (UMLS CUI 2011AB)
1086007 (SNOMEDCT_2012_01_31)
Item Group
Therapiephase
Erreichen des Therapiezieles der Induktionsphase (nach mindestens 24 Monaten Behandlung und 2-facher MMR) am:
Item
Erreichen des Therapiezieles der Induktionsphase (nach mindestens 24 Monaten Behandlung) am:
date
Achievement (Code-1)
C0001072 (UMLS CUI 2011AB)
treatment goals (Code-2)
C0679840 (UMLS CUI 2011AB)
Induction (Code-3)
C0857127 (UMLS CUI 2011AB)
10021721 (MedDRA 14.1)
Phase (Code-4)
C0205390 (UMLS CUI 2011AB)
21191007 (SNOMEDCT_2012_01_31)
Post (Code-5)
C0231290 (UMLS CUI 2011AB)
255234002 (SNOMEDCT_2012_01_31)
Minimum (Code-6)
C1524031 (UMLS CUI 2011AB)
Absetzdatum von Nilotinib im Kombinationsarm am:
Item
Absetzdatum von Nilotinib im Kombinationsarm am:
date
Date treatment stopped (observable entity) (Code-1)
C1531784 (UMLS CUI 2011AB)
413947000 (SNOMEDCT_2012_01_31)
Nilotinib (Code-2)
C1721377 (UMLS CUI 2011AB)
428468009 (SNOMEDCT_2012_01_31)
Combination (Code-3)
C1947911 (UMLS CUI 2011AB)
Protocol Treatment Arm (Code-4)
C1522541 (UMLS CUI 2011AB)
Erreichen der Hauptphase (nach mindestens 12 Monaten Behandlung und mindestens 12 Monaten kontinuierlicher MR4) am:
Item
Erreichen der Hauptphase (nach mindestens 12 Monaten Behandlung) am:
date
Achievement (Code-1)
C0001072 (UMLS CUI 2011AB)
Main (Code-2)
C1542147 (UMLS CUI 2011AB)
Phase (Code-3)
C0205390 (UMLS CUI 2011AB)
21191007 (SNOMEDCT_2012_01_31)
Post (Code-4)
C0231290 (UMLS CUI 2011AB)
255234002 (SNOMEDCT_2012_01_31)
Minimum (Code-5)
C1524031 (UMLS CUI 2011AB)
One (Code-6)
C0205447 (UMLS CUI 2011AB)
421379005 (SNOMEDCT_2012_01_31)
Absetzdatum der Hauptphasentherapie am:
Item
Absetzdatum der Hauptphasentherapie am:
date
Date treatment stopped (observable entity) (Code-1)
C1531784 (UMLS CUI 2011AB)
413947000 (SNOMEDCT_2012_01_31)
Main (Code-2)
C1542147 (UMLS CUI 2011AB)
Phase (Code-3)
C0205390 (UMLS CUI 2011AB)
21191007 (SNOMEDCT_2012_01_31)
Therapeutic procedure (Code-4)
C0087111 (UMLS CUI 2011AB)
277132007 (SNOMEDCT_2012_01_31)
10053757 (MedDRA 14.1)
MTHU021209 (LOINC Version 232)
Item Group
Bisherige Therapie im Intervall
Item Group
Nilotinib 2*300mg
andere Dosis (mg)
Item
andere Dosis (mg)
integer
Other (Code-1)
C0205394 (UMLS CUI 2011AB)
74964007 (SNOMEDCT_2012_01_31)
Dosage (Code-2)
C0178602 (UMLS CUI 2011AB)
260911001 (SNOMEDCT_2012_01_31)
Milligram (Code-3)
C0439210 (UMLS CUI 2011AB)
258684004 (SNOMEDCT_2012_01_31)
Beginn
Item
Beginn
date
Date treatment started (observable entity) (Code-1)
C3173309 (UMLS CUI 2011AB)
413946009 (SNOMEDCT_2012_01_31)
Nilotinib (Code-2)
C1721377 (UMLS CUI 2011AB)
427941004 (SNOMEDCT_2012_01_31)
Twice (Code-3)
C1948050 (UMLS CUI 2011AB)
Three (Code-4)
C0205449 (UMLS CUI 2011AB)
421291004 (SNOMEDCT_2012_01_31)
One Hundred (Code-5)
CL447292 (UMLS CUI 2011AB)
Milligram (Code-6)
C0439210 (UMLS CUI 2011AB)
258684004 (SNOMEDCT_2012_01_31)
Ende
Item
Ende
date
Date treatment stopped (observable entity) (Code-1)
C1531784 (UMLS CUI 2011AB)
413947000 (SNOMEDCT_2012_01_31)
Nilotinib (Code-2)
C1721377 (UMLS CUI 2011AB)
427941004 (SNOMEDCT_2012_01_31)
Twice (Code-3)
C1948050 (UMLS CUI 2011AB)
Three (Code-4)
C0205449 (UMLS CUI 2011AB)
421291004 (SNOMEDCT_2012_01_31)
One Hundred (Code-5)
CL447292 (UMLS CUI 2011AB)
Milligram (Code-6)
C0439210 (UMLS CUI 2011AB)
258684004 (SNOMEDCT_2012_01_31)
Therapietage
Item
Therapietage
integer
Number (Code-1)
C0449788 (UMLS CUI 2011AB)
410681005 (SNOMEDCT_2012_01_31)
Therapeutic procedure (Code-2)
C0087111 (UMLS CUI 2011AB)
277132007 (SNOMEDCT_2012_01_31)
10053757 (MedDRA 14.1)
MTHU021209 (LOINC Version 232)
day (Code-3)
C0439228 (UMLS CUI 2011AB)
258703001 (SNOMEDCT_2012_01_31)
MTHU039849 (LOINC Version 232)
D (HL7 V3 2006_05)
Nilotinib (Code-4)
C1721377 (UMLS CUI 2011AB)
427941004 (SNOMEDCT_2012_01_31)
Twice (Code-5)
C1948050 (UMLS CUI 2011AB)
Three (Code-6)
C0205449 (UMLS CUI 2011AB)
421291004 (SNOMEDCT_2012_01_31)
Gesamtdosis (mg)
Item
Gesamtdosis (mg)
integer
Cumulative Dose (Code-1)
C2986497 (UMLS CUI 2011AB)
Milligram (Code-2)
C0439210 (UMLS CUI 2011AB)
258684004 (SNOMEDCT_2012_01_31)
Nilotinib (Code-3)
C1721377 (UMLS CUI 2011AB)
427941004 (SNOMEDCT_2012_01_31)
Twice (Code-4)
C1948050 (UMLS CUI 2011AB)
Three (Code-5)
C0205449 (UMLS CUI 2011AB)
421291004 (SNOMEDCT_2012_01_31)
One Hundred (Code-6)
CL447292 (UMLS CUI 2011AB)
Item
Absetzen
integer
Stop (Code-1)
C1947925 (UMLS CUI 2011AB)
Nilotinib (Code-2)
C1721377 (UMLS CUI 2011AB)
427941004 (SNOMEDCT_2012_01_31)
Twice (Code-3)
C1948050 (UMLS CUI 2011AB)
Three (Code-4)
C0205449 (UMLS CUI 2011AB)
421291004 (SNOMEDCT_2012_01_31)
One Hundred (Code-5)
CL447292 (UMLS CUI 2011AB)
Milligram (Code-6)
C0439210 (UMLS CUI 2011AB)
258684004 (SNOMEDCT_2012_01_31)
Absetzen
Code List
Absetzen
CL Item
nein (nein)
No (Code-1)
C1298908 (UMLS CUI 2011AB)
373067005 (SNOMEDCT_2012_01_31)
CL Item
ja (ja)
Yes (Code-1)
C1298907 (UMLS CUI 2011AB)
373066001 (SNOMEDCT_2012_01_31)
Item
Grund für Absetzen
integer
Indication of (contextual qualifier) (Code-1)
C0392360 (UMLS CUI 2011AB)
410666004 (SNOMEDCT_2012_01_31)
MTHU008319 (LOINC Version 232)
Stop (Code-2)
C1947925 (UMLS CUI 2011AB)
Nilotinib (Code-3)
C1721377 (UMLS CUI 2011AB)
427941004 (SNOMEDCT_2012_01_31)
Twice (Code-4)
C1948050 (UMLS CUI 2011AB)
Three (Code-5)
C0205449 (UMLS CUI 2011AB)
421291004 (SNOMEDCT_2012_01_31)
One Hundred (Code-6)
CL447292 (UMLS CUI 2011AB)
Grund für Absetzen
Code List
Grund für Absetzen
CL Item
G=Geplantes Absetzen gemäß dem Therapieverlauf (G)
Stop (Code-1)
C1947925 (UMLS CUI 2011AB)
Plan (Code-2)
C1301732 (UMLS CUI 2011AB)
397943006 (SNOMEDCT_2012_01_31)
Course (Code-3)
C0750729 (UMLS CUI 2011AB)
288524001 (SNOMEDCT_2012_01_31)
Therapeutic procedure (Code-4)
C0087111 (UMLS CUI 2011AB)
277132007 (SNOMEDCT_2012_01_31)
10053757 (MedDRA 14.1)
MTHU021209 (LOINC Version 232)
CL Item
U=Unverträglichkeit (U)
Drug intolerance (Code-1)
C0277585 (UMLS CUI 2011AB)
59037007 (SNOMEDCT_2012_01_31)
10061822 (MedDRA 14.1)
DINT (HL7 V3 2006_05)
CL Item
A=Ablehnung des Patienten (A)
Treatment refused due to patient's wishes (Code-1)
C0852684 (UMLS CUI 2011AB)
10044558 (MedDRA 14.1)
CL Item
S=Sonstiges (S)
Other (Code-1)
C0205394 (UMLS CUI 2011AB)
74964007 (SNOMEDCT_2012_01_31)
Grund für Absetzen
Item
Grund für Absetzen
string
Indication of (contextual qualifier) (Code-1)
C0392360 (UMLS CUI 2011AB)
410666004 (SNOMEDCT_2012_01_31)
MTHU008319 (LOINC Version 232)
Stop (Code-2)
C1947925 (UMLS CUI 2011AB)
Free Text Format (Code-3)
C2348713 (UMLS CUI 2011AB)
Nilotinib (Code-4)
C1721377 (UMLS CUI 2011AB)
427941004 (SNOMEDCT_2012_01_31)
Twice (Code-5)
C1948050 (UMLS CUI 2011AB)
Three (Code-6)
C0205449 (UMLS CUI 2011AB)
421291004 (SNOMEDCT_2012_01_31)
Item Group
Nilotinib - Pause
Beginn
Item
Beginn
date
Start Date (Code-1)
C0808070 (UMLS CUI 2011AB)
MTHU008298 (LOINC Version 232)
Ende
Item
Ende
date
End Date (Code-1)
C0806020 (UMLS CUI 2011AB)
MTHU008302 (LOINC Version 232)
Item Group
PEG-IFN
Beginn
Item
Beginn
date
Date treatment started (observable entity) (Code-1)
C3173309 (UMLS CUI 2011AB)
413946009 (SNOMEDCT_2012_01_31)
Pegylated Interferon Alfa (Code-2)
C0907160 (UMLS CUI 2011AB)
Ende
Item
Ende
date
Date treatment stopped (observable entity) (Code-1)
C1531784 (UMLS CUI 2011AB)
413947000 (SNOMEDCT_2012_01_31)
Pegylated Interferon Alfa (Code-2)
C0907160 (UMLS CUI 2011AB)
Einzeldosis (μg)
Item
Einzeldosis (μg)
integer
Single dose characteristic (observable entity) (Code-1)
C1960417 (UMLS CUI 2011AB)
426146003 (SNOMEDCT_2012_01_31)
Microgram (Code-2)
C0439211 (UMLS CUI 2011AB)
258685003 (SNOMEDCT_2012_01_31)
Intervall (Tage)
Item
Intervall (Tage)
integer
Interval (Code-1)
C1272706 (UMLS CUI 2011AB)
385673002 (SNOMEDCT_2012_01_31)
Anzahl Injektionen
Item
Anzahl Injektionen
integer
Number (Code-1)
C0449788 (UMLS CUI 2011AB)
410681005 (SNOMEDCT_2012_01_31)
Injection procedure (Code-2)
C1533685 (UMLS CUI 2011AB)
129326001 (SNOMEDCT_2012_01_31)
10052995 (MedDRA 14.1)
Item
Absetzen
integer
Stop (Code-1)
C1947925 (UMLS CUI 2011AB)
Pegylated Interferon Alfa (Code-2)
C0907160 (UMLS CUI 2011AB)
Absetzen
Code List
Absetzen
CL Item
nein (nein)
No (Code-1)
C1298908 (UMLS CUI 2011AB)
373067005 (SNOMEDCT_2012_01_31)
CL Item
ja (ja)
Yes (Code-1)
C1298907 (UMLS CUI 2011AB)
373066001 (SNOMEDCT_2012_01_31)
Item
Grund für Absetzen
integer
Indication of (contextual qualifier) (Code-1)
C0392360 (UMLS CUI 2011AB)
410666004 (SNOMEDCT_2012_01_31)
MTHU008319 (LOINC Version 232)
Stop (Code-2)
C1947925 (UMLS CUI 2011AB)
Pegylated Interferon Alfa (Code-3)
C0907160 (UMLS CUI 2011AB)
Grund für Absetzen
Code List
Grund für Absetzen
CL Item
G=Geplantes Absetzen gemäß dem Therapieverlauf (G)
Stop (Code-1)
C1947925 (UMLS CUI 2011AB)
Plan (Code-2)
C1301732 (UMLS CUI 2011AB)
397943006 (SNOMEDCT_2012_01_31)
Course (Code-3)
C0750729 (UMLS CUI 2011AB)
288524001 (SNOMEDCT_2012_01_31)
Therapeutic procedure (Code-4)
C0087111 (UMLS CUI 2011AB)
277132007 (SNOMEDCT_2012_01_31)
10053757 (MedDRA 14.1)
MTHU021209 (LOINC Version 232)
CL Item
U=Unverträglichkeit (U)
Drug intolerance (Code-1)
C0277585 (UMLS CUI 2011AB)
59037007 (SNOMEDCT_2012_01_31)
10061822 (MedDRA 14.1)
DINT (HL7 V3 2006_05)
CL Item
A=Ablehnung des Patienten (A)
Treatment refused due to patient's wishes (Code-1)
C0852684 (UMLS CUI 2011AB)
10044558 (MedDRA 14.1)
CL Item
S=Sonstiges (S)
Other (Code-1)
C0205394 (UMLS CUI 2011AB)
74964007 (SNOMEDCT_2012_01_31)
Grund für Absetzen
Item
Grund für Absetzen
string
Indication of (contextual qualifier) (Code-1)
C0392360 (UMLS CUI 2011AB)
410666004 (SNOMEDCT_2012_01_31)
MTHU008319 (LOINC Version 232)
Stop (Code-2)
C1947925 (UMLS CUI 2011AB)
Free Text Format (Code-3)
C2348713 (UMLS CUI 2011AB)
Pegylated Interferon Alfa (Code-4)
C0907160 (UMLS CUI 2011AB)
Item Group
PEG-IFN - Pause
Beginn
Item
Beginn
date
Start Date (Code-1)
C0808070 (UMLS CUI 2011AB)
MTHU008298 (LOINC Version 232)
Pegylated Interferon Alfa (Code-2)
C0907160 (UMLS CUI 2011AB)
Rest (Code-3)
C0035253 (UMLS CUI 2011AB)
258157001 (SNOMEDCT_2012_01_31)
Ende
Item
Ende
date
End Date (Code-1)
C0806020 (UMLS CUI 2011AB)
MTHU008302 (LOINC Version 232)
Pegylated Interferon Alfa (Code-2)
C0907160 (UMLS CUI 2011AB)
Rest (Code-3)
C0035253 (UMLS CUI 2011AB)
258157001 (SNOMEDCT_2012_01_31)
Item Group
weitere Medikation
Grund
Item
Grund
string
Indication of (contextual qualifier) (Code-1)
C0392360 (UMLS CUI 2011AB)
410666004 (SNOMEDCT_2012_01_31)
MTHU008319 (LOINC Version 232)
Further (Code-2)
C1517331 (UMLS CUI 2011AB)
Pharmaceutical Preparations (Code-3)
C0013227 (UMLS CUI 2011AB)
410942007 (SNOMEDCT_2012_01_31)
Medikament
Item
Medikament
string
Pharmaceutical Preparations (Code-1)
C0013227 (UMLS CUI 2011AB)
410942007 (SNOMEDCT_2012_01_31)
Dosis
Item
Dosis
integer
Dosage (Code-1)
C0178602 (UMLS CUI 2011AB)
277406006 (SNOMEDCT_2012_01_31)
Einheit
Item
Einheit
string
Dosage Form Unit (Code-1)
C2348328 (UMLS CUI 2011AB)
Beginn
Item
Beginn
date
Date treatment started (observable entity) (Code-1)
C3173309 (UMLS CUI 2011AB)
413946009 (SNOMEDCT_2012_01_31)
Further (Code-2)
C1517331 (UMLS CUI 2011AB)
Pharmaceutical Preparations (Code-3)
C0013227 (UMLS CUI 2011AB)
410942007 (SNOMEDCT_2012_01_31)
Ende
Item
Ende
date
Date treatment stopped (observable entity) (Code-1)
C1531784 (UMLS CUI 2011AB)
413947000 (SNOMEDCT_2012_01_31)
Further (Code-2)
C1517331 (UMLS CUI 2011AB)
Pharmaceutical Preparations (Code-3)
C0013227 (UMLS CUI 2011AB)
410942007 (SNOMEDCT_2012_01_31)
Item Group
Unterschrift
Kommentar
Item
Kommentar
string
Comment (Code-1)
C0947611 (UMLS CUI 2011AB)
MTHU013736 (LOINC Version 232)
Klinik
Item
Klinik
string
Hospitals (Code-1)
C0019994 (UMLS CUI 2011AB)
MTHU002722 (LOINC Version 232)
Datum
Item
Datum
date
Signature date (Code-1)
C0807937 (UMLS CUI 2011AB)
MTHU008294 (LOINC Version 232)
Unterschrift
Item
Unterschrift
string
Investigator Signature (Code-1)
C2346576 (UMLS CUI 2011AB)
Back to the top of the page